Express Scripts Inc will buy health insurer WellPoint Inc's NextRx prescription business for $4.68 billion, becoming the No. 2 U.S. pharmacy benefit manager while gaining more leverage in driving down drug prices.
Drugmakers should deliver a solid set of quarterly results but investors will be watching for any signs of recession choking demand for more expensive treatments.
What's better than listening to a $20 relaxation CD at home? Having a relaxing massage for half the price on a white-sand beach. Boracay, one of the most commercialized islands of the Philippines, is a seven-kilometer-long paradise island where tourists flock to
China announced plans Wednesday to inject 850 billion yuan ($124 billion) into reforming its health care system over the next three years, according to a report.
Biotech firm Genentech Inc, recently acquired by Roche Holdings AG for $47 billion, said Wednesday that it has pulled its psoriasis drug Raptiva from the U.S. market because of its association with rare, but often fatal brain infection.
Microsoft and Google have been steadily adding partners to their competing health platforms, and both companies made new announcements today.
Results of a late-stage trial of MAP Pharmaceuticals Inc's inhaled migraine drug will represent a critical moment for the company given the recent failure of its other key drug to treat asthma in children.
Congress can fight the epidemic of childhood obesity by getting junk food out of school stores and snack machines, a parent-teacher group and the American Dietetic Association said on Tuesday.
Arena Pharmaceuticals said its experimental obesity drug helped patients shed only about 10 pounds more than those taking placebos, sending its shares down 27 percent.
President Barack Obama seized the wheel of the failing U.S. auto industry on Monday, forcing out General Motors Corp's chief executive, pushing Chrysler LLC toward a merger and threatening bankruptcy for both.
Japanese robots are helping hayfever suffers get through the allergy minefield that is spring by measuring the amount of pollen in the air and then warning about its severity.
Whether you like your body scrubbed with powdered black pearls, rubbed with hot jade stones, or wrapped in coca leaves, there’s a spa out there for you. Here’s a disappointing...
The Vatican Wednesday defended Pope Benedict's opposition to the use of condoms to stop the spread of AIDS as activists, doctors and politicians criticized it as unrealistic, unscientific and dangerous.
Pope Benedict arrived in Africa on Tuesday, where he said the continent's people were suffering disproportionately due to the global challenges of food shortages, financial crises and climate change.
The U.N. narcotics watchdog on Tuesday issued guidelines on how to crack down on Internet drug peddling at the request of governments struggling to contain growing abuse of prescription drugs.
As many as 75 percent of U.S. doctors will be writing electronic prescriptions within five years, thanks to new federal spending to encourage e-prescribing, according to a forecast released on Monday.
As many as 75 percent of U.S. doctors will be writing electronic prescriptions within five years, thanks to new federal spending to encourage e-prescribing, according to a forecast released on Monday.
Medecins Sans Frontiers (MSF) aid workers who were kidnapped on Wednesday were freed on Saturday evening; a Sudanese guard who was kidnapped along with them was not released.
It is buying up less than half of Genentech Inc for a whopping $46.8 billion, but Switzerland's Roche Holding AG may have clinched the best of this year's three big drug deals.
A study of Pfizer Inc's Sutent was halted early after the medicine delayed progression of a rare form of pancreatic cancer affecting tens of thousands of people globally, including Apple Inc CEO Steve Jobs.
Roche Holding AG has struck a deal with Genentech Inc to acquire all outstanding shares in the U.S. biotech group for $46.8 billion, the Swiss drugmaker said on Thursday.
Roche Holding AG has struck a deal with Genentech Inc to acquire all outstanding shares in the U.S. biotech group for $46.8 billion, the Swiss drugmaker said on Thursday.